# Tommorow.Bio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/tommorow-bio

- Industry: Healthcare
- Headquarters: Berlin, Germany
- Total disclosed funding: $5.7M
- Latest round: Seed (May 4, 2025)
- Investors on record: 2

## About

Based in Berlin, Germany, Tomorrow Biostasis GmbH, doing business as Tomorrow.Bio provides cryopreservation services for humans and pets, operating in both Europe and the United States. In May 2025, Tomorrow Biostasis GmbH raised EUR 5 million in seed funding co-led by Blast.Club and TruVenturo. 

The company offers whole-body field cryoprotection procedures and maintains long-term patient storage in a dedicated facility in Switzerland. Services include continuous medical standby and coordination with life insurance to fund cryopreservation. The organization also supports cryonics through a membership model and provides tools for estimating individual costs. Tomorrow Biostasis engages in research and development to improve biostasis techniques and collaborates with medical and scientific professionals to refine its procedures. The company emphasizes indefinite storage until potential future revival is feasible.

Tomorrow Biostasis GmbH offers a pricing plan consisting of a recurring membership fee for standby services and a separate fee for cryopreservation and long-term storage, typically funded through life insurance or paid upfront.

The company intends to use the May 2025 funding to expand across the US and improve product research and development.

## Funding rounds

- Seed, May 4, 2025, $5.7M — TruVenturo, Blast.Club

## Investors

- TruVenturo (https://capitalatlas.ai/funds/truventuro) — Seed
- Blast.Club (https://capitalatlas.ai/funds/blast-club) — Seed